Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Athanasios Dellis

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Journal of Frailty, Sarcopenia and Falls|September 19, 2022
Outcomes of radical cystectomy in pT4 bladder cancer frail patients: Α high-volume single center studyPanagiotis Velissarios Stamatakos, Dimitrios Moschotzopoulos, Ioannis Glykas, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|December 28, 2022
Clinical impact of ERG and PTEN status in prostate cancer patients underwent radical prostatectomyCharalampos Fragkoulis, Ioannis Glykas, Lazaros Tzelves, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|July 1, 2022
An update on the management algorithms of priapism during the last decadeMohamad Moussa, Mohamad Abou Chakra, Athanasios Papatsoris, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|April 4, 2019
PI3K/AKT pathway genetic alterations and dysregulation of expression in bladder cancerStefanos Kachrilas, Athanasios Dellis, Athanasios Papatsoris, et al.
The Oncologist|June 9, 2017
Current Clinical Practice Guidelines for the Treatment of Renal Cell Carcinoma: A Systematic Review and Critical EvaluationAristotle Bamias, Bernard Escudier, Cora N Sternberg, et al.
Vaccines|October 26, 2021
Nocebo-Prone Behavior Associated with SARS-CoV-2 Vaccine Hesitancy in Healthcare WorkersDimos D Mitsikostas, Konstantina Aravantinou-Fatorou, Christina Deligianni, et al.
Cancer Management and Research|August 6, 2021
Referral for "Neoadjuvant Chemotherapy" for Muscle-Invasive Bladder Cancer to a Multidisciplinary Board: Patterns, Management and OutcomesAthanasios Dellis, Roubini Zakopoulou, Andromahi Kougioumtzopoulou, et al.
Anti-Cancer Drugs|October 1, 2015
Treatment of relapsed urothelial bladder cancer with vinflunine: real-world evidence by the Hellenic Genitourinary Cancer GroupNikolaos Pistamaltzian, Kimon Tzannis, Vassiliki Pissanidou, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|November 13, 2018
Patterns of practice and pharmacoeconomic analysis of the management of patients with metastatic renal cell carcinoma (mRCC) in Greece--the CRISIS study. A retrospective analysis by the Hellenic Genitourinary Cancer Group (HGUCG)Georgiops Tsironis, Konstantinos Koutsoukos, Konstantinos Athanasakis, et al.
Current Oncology (Toronto, Ont.)|December 13, 2021
ERCC1 19007 Polymorphism in Greek Patients with Advanced Urothelial Cancer Treated with Platinum-Based Chemotherapy: Effect of the Changing Treatment Paradigm: A Cohort Study by the Hellenic GU Cancer GroupAristotelis Bamias, Konstantinos Koutsoukos, Nikos Gavalas, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Journal of Frailty, Sarcopenia and Falls|September 19, 2022
Outcomes of radical cystectomy in pT4 bladder cancer frail patients: Α high-volume single center studyPanagiotis Velissarios Stamatakos, Dimitrios Moschotzopoulos, Ioannis Glykas, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|December 28, 2022
Clinical impact of ERG and PTEN status in prostate cancer patients underwent radical prostatectomyCharalampos Fragkoulis, Ioannis Glykas, Lazaros Tzelves, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|July 1, 2022
An update on the management algorithms of priapism during the last decadeMohamad Moussa, Mohamad Abou Chakra, Athanasios Papatsoris, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|April 4, 2019
PI3K/AKT pathway genetic alterations and dysregulation of expression in bladder cancerStefanos Kachrilas, Athanasios Dellis, Athanasios Papatsoris, et al.
The Oncologist|June 9, 2017
Current Clinical Practice Guidelines for the Treatment of Renal Cell Carcinoma: A Systematic Review and Critical EvaluationAristotle Bamias, Bernard Escudier, Cora N Sternberg, et al.
Vaccines|October 26, 2021
Nocebo-Prone Behavior Associated with SARS-CoV-2 Vaccine Hesitancy in Healthcare WorkersDimos D Mitsikostas, Konstantina Aravantinou-Fatorou, Christina Deligianni, et al.
Cancer Management and Research|August 6, 2021
Referral for "Neoadjuvant Chemotherapy" for Muscle-Invasive Bladder Cancer to a Multidisciplinary Board: Patterns, Management and OutcomesAthanasios Dellis, Roubini Zakopoulou, Andromahi Kougioumtzopoulou, et al.
Anti-Cancer Drugs|October 1, 2015
Treatment of relapsed urothelial bladder cancer with vinflunine: real-world evidence by the Hellenic Genitourinary Cancer GroupNikolaos Pistamaltzian, Kimon Tzannis, Vassiliki Pissanidou, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|November 13, 2018
Patterns of practice and pharmacoeconomic analysis of the management of patients with metastatic renal cell carcinoma (mRCC) in Greece--the CRISIS study. A retrospective analysis by the Hellenic Genitourinary Cancer Group (HGUCG)Georgiops Tsironis, Konstantinos Koutsoukos, Konstantinos Athanasakis, et al.
Current Oncology (Toronto, Ont.)|December 13, 2021
ERCC1 19007 Polymorphism in Greek Patients with Advanced Urothelial Cancer Treated with Platinum-Based Chemotherapy: Effect of the Changing Treatment Paradigm: A Cohort Study by the Hellenic GU Cancer GroupAristotelis Bamias, Konstantinos Koutsoukos, Nikos Gavalas, et al.
Pageof 9